VVUS 3.07 Vivus Inc $VVUS Hit a 52 week low of 3.05 Closing

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
VVUS 3.07 Vivus Inc $VVUS Hit a 52 week low of 3.05 Closing the day 10:44 at 3.07 -0.04 -1.29% With a day low of 3.05 and a total volume of 453,844.

VVUS Recent Posts: http://investorshangout.com/VIVUS-Inc-VVUS-55858/

VVUS Vivus Inc Recent Headline News

Janssen Is Working Its Way Toward Anti-Obesity
Spencer Osborne - at Seeking Alpha - Mon Nov 17, 4:14PM CST

ZFGN: 20.30 (+0.18), OREX: 5.59 (+0.08), NVO: 44.13 (+0.53), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

EnteroMedics May Enter The Obesity Space - What Does It Mean?
Spencer Osborne - at Seeking Alpha - Mon Nov 17, 3:43PM CST

OREX: 5.59 (+0.08), ETRM: 1.28 (-0.01), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

For This Obesity Drug, Europe Trumps the U.S.
Brian Orelli, The Motley Fool - Motley Fool - Mon Nov 17, 3:00PM CST
The launch of Orexigen Therapeutics ' obesity drug Contrave isn't off to the best start. As Chief Commercial Officer Mark Booth put it during the company's latest conference call: Unfortunately, like many new tactics, there have been some...
OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

ARNA Management And Investors Underestimating The Potential Of Belviq And Phentermine Combination
Lance Brofman - at Seeking Alpha - Thu Nov 13, 8:52AM CST

OREX: 5.59 (+0.08), HLF: 38.39 (-0.11), NVO: 44.13 (+0.53), VVUS: 3.07 (-0.04), AMGN: 160.83 (+1.69), GSK: 46.26 (+0.38), ARNA: 4.46 (-0.04)

Critical Alerts For American Eagle Outfitters, Novartis, VIVUS, King Digital and Canadian Solar Released By InvestorsObserver
PR Newswire - Thu Nov 13, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for AEO, NVS, VVUS, KING and CSIQ.
AEO: 13.20 (-0.14), VVUS: 3.07 (-0.04), CSIQ: 26.89 (+0.52), KING: 15.69 (-0.16), NVS: 95.71 (+1.33)

Bel-Phen Pilot Study News, Hold On To Your Shares
Rx Stocks - at Seeking Alpha - Tue Nov 11, 12:13PM CST

OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

Orexigen Turns Around with Q3 Earnings Beat, Shares Soar - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 10:20AM CST
Orexigen (OREX) swung to profit in the third quarter of 2014 with earnings of 9 cents per share beating the Zacks Consensus Estimate of 5 cents.
OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), AMAG: 36.28 (+1.52)

Can Arena Pharmaceuticals Inc. Overcome Belviq's Slow Launch?
George Budwell, The Motley Fool - Motley Fool - Tue Nov 11, 10:15AM CST
The new generation of diet pills approved by the Food and Drug Administration have stumbled out of the gate. Specifically,  Arena Pharmaceuticals '   Belviq and  VIVUS 's   Qsymia reported a combined 283,000 prescriptions in the third quarter, with...
PFE: 30.58 (+0.26), VVUS: 3.07 (-0.04), GSK: 46.26 (+0.38), ARNA: 4.46 (-0.04)

Why Orexigen Therapeutics, Inc. Stock Skyrocketed
Sean Williams, The Motley Fool - Motley Fool - Mon Nov 10, 5:52PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Orexigen Therapeutics , a...
OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

Arena And Vivus Investors Need To Watch Orexigen
Spencer Osborne - at Seeking Alpha - Mon Nov 10, 12:24PM CST

OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

Orexigen rises as weight loss drug review proceeds
AP - Mon Nov 10, 10:02AM CST
NEW YORK (AP) — Shares of Orexigen Therapeutics Inc. jumped Monday after the company said a European Union review of its weight loss drug Contrave, which was approved in the U.S. in September, is progressing on schedule.
OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

3 Crashing Stocks: Is 1 a Buy?
Motley Fool Staff - Motley Fool - Sun Nov 09, 10:45AM CST
Even though the overall stock market is very close to its record highs, many stocks have not fared so well. In fact, some stocks have gotten crushed recently. We asked three of our analysts to give their opinions on stocks that have been beaten...
VVUS: 3.07 (-0.04), SNY: 48.28 (+0.74), GNW: 9.35 (+0.02), REGN: 410.83 (+11.18)

Belviq Sales Dip Slightly - Quarter Is Flat Thus Far
Spencer Osborne - at Seeking Alpha - Fri Nov 07, 12:02PM CST

VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

VIVUS Posts Narrower-than-Expected Q3 Loss, Revenues Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 3:45PM CST
VIVUS Inc.'s (VVUS) third-quarter 2014 loss of 11 cents per share was much narrower than the Zacks Consensus Estimate of a loss of 21 cents.
AUXL: 32.97 (+0.79), VVUS: 3.07 (-0.04), AMAG: 36.28 (+1.52), SNY: 48.28 (+0.74)

Vivus Beats The Street On Milestone Payment For ED Drug
Spencer Osborne - at Seeking Alpha - Thu Nov 06, 7:59AM CST

OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

Will Belviq Advertising Pick Up Again?
Spencer Osborne - at Seeking Alpha - Thu Nov 06, 7:55AM CST

VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

VIVUS' (VVUS) CEO Seth Fischer on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 6:18PM CST

VVUS: 3.07 (-0.04)

Vivus tops Street 3Q forecasts
Automated Insights - Wed Nov 05, 4:45PM CST
MOUNTAIN VIEW, Calif. (AP) _ Vivus Inc. (VVUS) on Wednesday reported a third-quarter loss of $15.8 million.
VVUS: 3.07 (-0.04)

Vivus Q3 revenues up 24%
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:29PM CST

VVUS: 3.07 (-0.04)

Vivus (VVUS) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 3:25PM CST

VVUS: 3.07 (-0.04)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Veterans, Lawmakers Forge Paths in Spokane Forum

Updated Category News Views 45

Spokane Forum Sparks Action for Veterans' Policies Gonzaga University turned into a powerhouse of dialogue and determination as the Wounded Warrior Project (WWP) gathered over 145 veterans, elected officials, and advocate groups to hash out critical policy priorities. We're talking high-stakes discussions with real consequences, not just some feel-good meet-up. A...

Continue Reading
Bank of America Faces Class-Action Suit in Court

Updated Category News Views 49

Mixed Bag for Bank of America Investors If you thought you could just park your cash in big banks and slumber through the financial year, think again. Bank of America (NYSE: BAC) has found itself in hot water with a securities fraud class-action suit looming over what some are calling a pretty nasty oversight in compliance. A 4.76% stock drop was a bitter sip for those...

Continue Reading
National Civics Day: LIU Unveils Screen-Free Platform

Updated Category News Views 0

A Tradition Reimagined for a Milestone You ever look at a calendar and feel the weight of history? That's what's happening right now at Long Island University as America hits 250 years in the books. We're not just polishing dusty history statues—on October 27, there's a genuine push to get back to basics. Brian Kilmeade's stepping into the spotlight as he headlines this...

Continue Reading
Findity and Sage Team Up for Spanish Market Push

Updated Category News Views 104

Spain Joins the Expense Automation Revolution Expense management, a task as mundane as a soggy sandwich and just as appealing, is getting a facelift in Spain thanks to Findity and Sage's newly expanded partnership. After making waves in the UK, they're now targeting Spain with Sage Expenses, poised to spruce up the balance sheets and free up time for small and mid-sized...

Continue Reading
Fulcra Unveils DIY Web App Tool for AI Agent Users

Updated Category News Views 0

Fulcra Dynamics Pushes the Boundaries with New Tool There's always that moment when a company nudges the needle, and Fulcra Dynamics seems to have done just that with its latest release. They've unveiled an ingenious tool that promises a shake-up in how we build and use web applications with AI. It's the kind of move that makes you stop and wonder if we're witnessing the...

Continue Reading
Unlock Technologies Secures $433.1M in HEA Securitization

Updated Category News Views 238

An Unconventional Wave of Funding Ain't it a sight to see? One year you're hawking tech stocks, the next, you're up to your elbows in home equity agreements (HEAs). That's where Unlock Technologies finds itself. They've just wrapped up their ninth HEA securitization, a hefty $433.1 million, under the watchful eye of D2 Asset Management. This is no minor league...

Continue Reading
E-Filing: Why Ditching IRS Paper Forms Matters Now

Updated Category News Views 135

Tax Filing Today: The Old vs. The New Listen up, tax-filing warriors. Tackling that IRS Form 941 deadline isn’t just another play in the small business game—it’s crunch time. November 2, 2026, isn’t waiting around for excuses. Luckily, Halfpricesoft.com just chucked you a lifeline with their updated ezPaycheck platform. Swap that mountain of mangled paper forms...

Continue Reading
AppLovin Faces Securities Class Action Amid Share Plunge

Updated Category News Views 48

AppLovin's Fall from Grace AppLovin Corporation's recent tumble from investor darling to beleaguered party in a securities class action isn’t just a misstep; it’s a full-fledged nosedive into troubled waters that no trader worth their salt would want to ignore. The story kicks off with a pair of sharply disappointing turns that sent shivers down the spines of anyone...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 132

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
Surgery Partners Buyout: Fair Deal or Insider Jackpot?

Updated Category News Views 16

What's Going On With Surgery Partners? Alright, here's the scoop that shareholders can't ignore—Surgery Partners (NYSE:SGRY) could be heading under the scalpel itself with a proposed buyout by HealthSpan. For those holding onto SGRY stock, this might feel like watching the rerun of a medical drama where the ending ain't clear yet. Shareholders are set to get $23.50 a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring New Frontiers: Greenridge's Uranium Ambitions

Updated Category News Views 152

Revolutionizing Uranium Exploration at McKenzie Lake Greenridge Exploration Inc. (CSE: GXP | FRA: HW3 | OTCQB: GXPLF) is initiating a new chapter in uranium exploration at its McKenzie Lake project, located in the renowned Athabasca Basin. By partnering with Axiom Exploration Group Ltd. to conduct a helicopter-borne time-domain electromagnetic (HTDEM) survey, Greenridge...

Continue Reading
NOVA Collective Invest's Strategic Insights for 2025 Highlighting Global Trends

Updated Category News Views 328

Global Performance Insights and Strategic Shifts NOVA Collective Invest has recently unveiled its 2025 Half-Year Performance and Strategic Allocation Report. This comprehensive document provides a thorough examination of their capital deployment, portfolio returns, and investment positioning across several continents. The report showcases the organization's unwavering...

Continue Reading
Jackbit: The Ultimate No-KYC Crypto Casino in Canada

Updated Category News Views 326

Jackbit Leading the Way in Canada’s Crypto Casino Scene In recent years, online gambling has taken a significant turn, particularly in Canada. One casino that stands out in this evolving market is Jackbit, which has gained recognition for its unique approach to privacy and user experience. The platform allows players to enjoy online gambling without the usual burdens of...

Continue Reading
Exploring the Role of AI in Transforming Diabetic Retinopathy Care

Updated Category News Views 182

Understanding the Importance of AI in Diabetic Retinopathy The Global AI in Diabetic Retinopathy market is on a trajectory for substantial growth as artificial intelligence (AI) increasingly reshapes healthcare diagnostics and therapies. The use of AI technology is proving transformative, especially in the area of diabetic retinopathy (DR), a complicating factor for...

Continue Reading
Southwest Airlines Adjusts Profit Forecast Amid Rising Costs

Updated Category News Views 161

Southwest Airlines Reassesses Financial Expectations Southwest Airlines Co. (NYSE: LUV) has recently adjusted its profit forecast for the upcoming year as it navigates challenging market conditions. The airline's decision comes in response to a rise in fuel prices and a temporary decline in travel demand prompted by various disruptions. Impact of Increased Costs The...

Continue Reading